Which has grown faster, BIO or HIMS?

Over the past five years, HIMS grew revenue faster — BIO at a -0.84% CAGR versus HIMS at 69.19%.

Is BIO or HIMS more profitable?

BIO runs the higher net margin — BIO at 6.52% versus HIMS at -0.56%.

Which has been the better investment, BIO or HIMS?

Over the past 5-year, HIMS delivered the higher annualized total return — BIO at 6.91% versus HIMS at 17.04%. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Hims & Hers Health, Inc. (HIMS)

BIO leads on 7 of 12 compared metrics.

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Hims & Hers Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BIO

Bio-Rad Laboratories, Inc.

$7.73B

$285.94Healthcare

HIMS

Hims & Hers Health, Inc.

$5.98B

$26.82Healthcare

Total return — BIO vs HIMS

growth of $100 · last 7y

BIO -14.5%HIMS +173.7%HIMS compounded faster

BIO HIMS

BIO vs HIMS: by the numbers

•BIO is the larger company ($7.73B vs $5.98B market cap).
•BIO is profitable (6.52% net margin) while HIMS runs a net loss (-0.56%).
•HIMS grew revenue faster over the past five years (69.19% vs -0.84% CAGR).

Which is better, BIO or HIMS?

Metric tally: BIO 7 · HIMS 5

It depends on what you're optimizing for:

GrowthHIMS(faster 5Y revenue CAGR)

QualityHIMS(higher ROIC)

Valuation

Metric	BIO	HIMS
P/E ratio	47.11	—
Forward P/E	28.69●	56.93
P/S ratio	2.98	2.58●
P/B ratio	1.13●	13.73
EV / EBITDA	20.01●	234.03
FCF yield	4.63%●	1.24%

Profitability

Metric	BIO	HIMS
Gross margin	51.87%	67.64%●
Operating margin	9.25%●	1.32%
Net margin	6.52%●	-0.56%
ROE	2.46%●	-2.97%
ROIC	2.04%	6.02%●

Growth (annualized)

Metric	BIO	HIMS
Revenue CAGR (5Y)	-0.84%	69.19%●
EPS CAGR (5Y)	-26.27%	—
FCF CAGR (5Y)	-7.57%	—
Total return CAGR (5Y)	-13.82%	17.04%●

Frequently asked

Which is better, BIO or HIMS?: It depends on your goal. growth: HIMS (faster 5Y revenue CAGR); quality: HIMS (higher ROIC). Across all compared metrics, BIO leads 7 to 5.
Which has grown faster, BIO or HIMS?: Over the past five years, HIMS grew revenue faster — BIO at a -0.84% CAGR versus HIMS at 69.19%.
Is BIO or HIMS more profitable?: BIO runs the higher net margin — BIO at 6.52% versus HIMS at -0.56%.
Which has been the better investment, BIO or HIMS?: Over the past 5-year, HIMS delivered the higher annualized total return — BIO at 6.91% versus HIMS at 17.04%. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full HIMS analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Hims & Hers Health P/E ratio Bio-Rad Laboratories dividend yield Hims & Hers Health dividend yield Bio-Rad Laboratories ROE Hims & Hers Health ROE Bio-Rad Laboratories operating margin Hims & Hers Health operating margin Bio-Rad Laboratories revenue growth Hims & Hers Health revenue growth Bio-Rad Laboratories free cash flow Hims & Hers Health free cash flow

Bio-Rad Laboratories & Hims & Hers Health appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.